Posted on 12/17/20
SCYNEXIS Prices of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants . . .
Posted on 12/17/20
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) . . .
Posted on 12/17/20
What Pfizer's Vaccine Authorization Means for Moderna
The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE:PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet . . .
Posted on 12/17/20
3 Things Pfizer's Coronavirus Vaccine Still Has to Prove
The U.S. Food and Drug Administration met with its vaccines advisory panel of experts on Dec. 10 to discuss Pfizer's (NYSE:PFE) coronavirus vaccine candidate. The FDA . . .
Posted on 12/17/20
Is Teladoc Stock a Buy?
Telehealth has been growing in popularity this year, as patients are in need of much more flexible healthcare options amid the coronavirus pandemic. With hospitals deferring . . .
Posted on 12/17/20
Is This Recent IPO Stock The Teladoc of Medicare?
The world has clearly shifted to online aggregation platforms that simplify peoples' lives and make complicated choices more efficient. Whether it be used cars -- think . . .
Posted on 12/17/20
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) . . .
Posted on 12/17/20
What Pfizer's Vaccine Authorization Means for Moderna
The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE:PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet . . .
Posted on 12/17/20
Where Will CVS Health Be in 5 Years?
Only five years ago, investors were bidding up shares of CVS Health (NYSE:CVS) as the company took over Target's (NYSE:TGT) pharmacy business and acquired a business . . .
Posted on 12/17/20
SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has commenced an underwritten public offering of shares of its . . .
Posted on 12/17/20
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
GAITHERSBURG, Md., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an . . .
Posted on 12/16/20
Maryland’s Daily Number of New Coronavirus Deaths Continues to Rise
Maryland officials on Wednesday reported 64 more coronavirus-related deaths, the highest daily death total in seven months since the state reported 70 deaths on May 12.Since . . .
Posted on 12/16/20
TG Therapeutics Prices Upsized Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced . . .
Posted on 12/16/20
Exo Therapeutics Launches with $25 Million Series A Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion . . .
Posted on 12/16/20
Vesper Healthcare Acquisition: Another SPAC To Own
SummaryVesper Healthcare Acquisition agrees to acquire HydraFacial in a deal valued at up to $1.1 billion.The experiential beauty health company is looking to build a platform . . .
Posted on 12/16/20
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. An EUA for Moderna's (NASDAQ:MRNA) vaccine could be only days away. In . . .
Posted on 12/16/20
Could Novavax Be a Millionaire-Maker Stock?
If you owned shares of Novavax (NASDAQ:NVAX) at the beginning of 2020, you're probably a happy camper right now. Its shares have skyrocketed more than 3,000%. . . .
Posted on 12/16/20
4 Reasons to Buy Novavax in 2021
If you thought the market was crazy about vaccine stocks this year, just wait until 2021. As coronavirus vaccines are distributed to the public and a . . .
Posted on 12/16/20
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. An EUA for Moderna's (NASDAQ:MRNA) vaccine could be only days away. In . . .
Posted on 12/16/20
3 Buffett Stocks to Avoid Like the Plague
Few investors on Wall Street are more influential than Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) CEO Warren Buffett. That's because almost no one can hold a candle to the . . .
Posted on 12/16/20
Why Moderna Got Slammed on Tuesday
What happenedThere was good news with Moderna (NASDAQ:MRNA) on Tuesday regarding its closely followed mRNA-1273 coronavirus vaccine candidate. However, comments made by a health expert who . . .
Posted on 12/16/20
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
With all the recent focus on COVID-19 vaccines and the successes of a new gene-based approach to developing drugs, it's understandable that investors might lose sight . . .
Posted on 12/16/20
State Roundup: Vaccines Could Start Arriving In Maryland This Week
VACCINES EXPECTED TO ARRIVE THIS WEEK: As coronavirus cases continue to rise, doses of a highly anticipated vaccine could start arriving in Maryland as soon as . . .
Posted on 12/16/20
Arvinas Prices $400M Public Offering of Common Stock
NEW HAVEN, Conn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/16/20
AdaptHealth Prices $500M Senior Notes
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, . . .

